Long-term therapy of Kaposi’s sarcoma with the use of prospidium chloride and mTOR receptor inhibitors in а patient after kidney transplantation
Published: 10 September 2020
Transplantologiya. The Russian Journal of Transplantation , Volume 12; doi:10.23873/2074-0506-2020-12-3-213-219
Abstract: A case of a long-term management of a patient with Kaposi’s sarcoma developed as presumably related to a “standard” immunosuppressive therapy after kidney transplantation has been described. Immunosuppressive therapy conversion to mTOR receptor inhibitors and administering chemotherapy with prospidium chloride allowed for a long-term remission of the disease and a satisfactory clinical outcome.
Click here to see the statistics on "Transplantologiya. The Russian Journal of Transplantation" .